Cargando…

Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality

INTRODUCTION: Pulmonary capillary endothelium-bound (PCEB) angiotensin-converting enzyme (ACE) activity is a direct and quantifiable index of pulmonary endothelial function that decreases early in acute respiratory distress syndrome (ARDS) and correlates with its severity. Endothelial dysfunction is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaziani, Katerina, Vassiliou, Alice G., Kotanidou, Anastasia, Athanasiou, Chariclea, Korovesi, Ioanna, Glynos, Konstantinos, Orfanos, Stylianos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856732/
https://www.ncbi.nlm.nih.gov/pubmed/29549655
http://dx.doi.org/10.1007/s40121-018-0192-3
_version_ 1783307326846926848
author Kaziani, Katerina
Vassiliou, Alice G.
Kotanidou, Anastasia
Athanasiou, Chariclea
Korovesi, Ioanna
Glynos, Konstantinos
Orfanos, Stylianos E.
author_facet Kaziani, Katerina
Vassiliou, Alice G.
Kotanidou, Anastasia
Athanasiou, Chariclea
Korovesi, Ioanna
Glynos, Konstantinos
Orfanos, Stylianos E.
author_sort Kaziani, Katerina
collection PubMed
description INTRODUCTION: Pulmonary capillary endothelium-bound (PCEB) angiotensin-converting enzyme (ACE) activity is a direct and quantifiable index of pulmonary endothelial function that decreases early in acute respiratory distress syndrome (ARDS) and correlates with its severity. Endothelial dysfunction is a major pathophysiology that underlies sepsis-related ARDS. Recombinant human activated protein C (rhAPC), now withdrawn from the market, has been used in the recent past as an endothelial-protective treatment in patients with septic organ dysfunction. METHODS: We investigated the effect of rhAPC on pulmonary endothelial function in 19 septic patients suffering from ARDS. Applying indicator-dilution type techniques, we measured single-pass transpulmonary percent metabolism (%M) and hydrolysis (v) of the synthetic, biologically inactive, and highly specific for ACE substrate, (3)H-benzoyl-Phe-Ala-Pro (BPAP), under first-order reaction conditions, and calculated lung functional capillary surface area before and after treatment with rhAPC. RESULTS: Pulmonary endothelium ACE activity was severely impaired in septic patients with ARDS, and was not affected by rhAPC treatment. Additionally, poor outcome was related to a more profound decrease in PCEB-ACE activity. Angiotensin-converting enzyme–substrate utilization was statistically significantly lower in non-survivors as compared to survivors, with no changes over time within each group: BPAP %M: 32.7 ± 3.4% at baseline to 25.6 ± 2.9% at day 7 in survivors versus 20.8 ± 2.8 to 15.5 ± 5%, respectively, in non-survivors (p = 0.044), while hydrolysis (v): 0.41 ± 0.06 at baseline to 0.30 ± 0.04 at day 7 in survivors compared to 0.24 ± 0.04 to 0.18 ± 0.06, respectively, in non-survivors (p = 0.049). CONCLUSION: rhAPC administration in septic patients with ARDS did not improve PCEB-ACE activity indices. However, these indices might be useful in the early recognition of septic patients with ARDS at high risk of mortality.
format Online
Article
Text
id pubmed-5856732
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-58567322018-03-21 Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality Kaziani, Katerina Vassiliou, Alice G. Kotanidou, Anastasia Athanasiou, Chariclea Korovesi, Ioanna Glynos, Konstantinos Orfanos, Stylianos E. Infect Dis Ther Original Research INTRODUCTION: Pulmonary capillary endothelium-bound (PCEB) angiotensin-converting enzyme (ACE) activity is a direct and quantifiable index of pulmonary endothelial function that decreases early in acute respiratory distress syndrome (ARDS) and correlates with its severity. Endothelial dysfunction is a major pathophysiology that underlies sepsis-related ARDS. Recombinant human activated protein C (rhAPC), now withdrawn from the market, has been used in the recent past as an endothelial-protective treatment in patients with septic organ dysfunction. METHODS: We investigated the effect of rhAPC on pulmonary endothelial function in 19 septic patients suffering from ARDS. Applying indicator-dilution type techniques, we measured single-pass transpulmonary percent metabolism (%M) and hydrolysis (v) of the synthetic, biologically inactive, and highly specific for ACE substrate, (3)H-benzoyl-Phe-Ala-Pro (BPAP), under first-order reaction conditions, and calculated lung functional capillary surface area before and after treatment with rhAPC. RESULTS: Pulmonary endothelium ACE activity was severely impaired in septic patients with ARDS, and was not affected by rhAPC treatment. Additionally, poor outcome was related to a more profound decrease in PCEB-ACE activity. Angiotensin-converting enzyme–substrate utilization was statistically significantly lower in non-survivors as compared to survivors, with no changes over time within each group: BPAP %M: 32.7 ± 3.4% at baseline to 25.6 ± 2.9% at day 7 in survivors versus 20.8 ± 2.8 to 15.5 ± 5%, respectively, in non-survivors (p = 0.044), while hydrolysis (v): 0.41 ± 0.06 at baseline to 0.30 ± 0.04 at day 7 in survivors compared to 0.24 ± 0.04 to 0.18 ± 0.06, respectively, in non-survivors (p = 0.049). CONCLUSION: rhAPC administration in septic patients with ARDS did not improve PCEB-ACE activity indices. However, these indices might be useful in the early recognition of septic patients with ARDS at high risk of mortality. Springer Healthcare 2018-03-16 2018-03 /pmc/articles/PMC5856732/ /pubmed/29549655 http://dx.doi.org/10.1007/s40121-018-0192-3 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Kaziani, Katerina
Vassiliou, Alice G.
Kotanidou, Anastasia
Athanasiou, Chariclea
Korovesi, Ioanna
Glynos, Konstantinos
Orfanos, Stylianos E.
Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality
title Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality
title_full Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality
title_fullStr Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality
title_full_unstemmed Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality
title_short Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality
title_sort activated protein c has no effect on pulmonary capillary endothelial function in septic patients with acute respiratory distress syndrome: association of endothelial dysfunction with mortality
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856732/
https://www.ncbi.nlm.nih.gov/pubmed/29549655
http://dx.doi.org/10.1007/s40121-018-0192-3
work_keys_str_mv AT kazianikaterina activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality
AT vassilioualiceg activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality
AT kotanidouanastasia activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality
AT athanasiouchariclea activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality
AT korovesiioanna activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality
AT glynoskonstantinos activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality
AT orfanosstylianose activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality